# A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.

> **NCT07320521** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 6 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** [14C]HRS-8080

## Key facts

- **NCT ID:** NCT07320521
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07320521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07320521, "A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07320521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*